Top compounds associated with response to SPRY1


Feature Type Standardized
Nominal ANOVA
mRNA ML320 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA PIK-93 CTRPv2 pan-cancer AAC 0.046 0.2
mRNA MI-1 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC -0.078 0.2
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.04 0.2
mRNA manumycin A CTRPv2 pan-cancer AAC -0.041 0.2
Download CSV